Sign in
4

Changes in Ownership

Caribou Biosciences, Inc. Filed Acc 0001209191-22-028170

President and CEO acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Haurwitz Rachel E. President and CEO 2022-05-09 Option exercise +10,000 $2.96 $29,600 20,000 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Haurwitz Rachel E. President and CEO 2022-05-09 Option exercise · Option to purchase Common Stock −10,000 116,350 D: show line 2 in the form
Loading xslF345X03/doc4.xml…